Direct-to-consumer advertising distorts prescription drugs’ benefits and costs
Common Sense Family Doctor
FEBRUARY 15, 2025
In 1998, a Letter to the Editor in American Family Physician expressed concerns about the relatively new practice of pharmaceutical advertising directly to patients. The annual price of risankizumab is $288,000, so this is still a huge bargain for the company given the potential returns.
40 
Let's personalize your content